Clinical Trial Update: A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating LY3938577 in adults with type 2 diabetes previously treated with basal insulin; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LY3938577

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: RECRUITING